Encequidar is an inhibitor of the adenosine triphosphate (ATP)-binding cassette (ABC) transporter P-glycoprotein (P-gp), with adjuvant activity. Upon oral administration, encequidar selectively binds to and inhibits the multidrug resistance (MDR) efflux pump P-gp, which prevents the efflux of various chemotherapeutic agents from intestinal epithelial cells to the gastrointestinal tract. This leads to an increase in both oral bioavailability and therapeutic efficacy. P-gp prevents the intestinal uptake and intracellular accumulation of various cytotoxic agents. Encequidar is not systemically absorbed. The directory classifies it as a clinical API with a synthetic source/manufacturing origin. Other names for this substance include Pgp inhibitor hm30181ak and encequidarum. Its PubChem CID is 11399764.
Encequidar
| CAS No | 849675-66-7 |
|---|---|
| Molecular Formula | C38H36N6O7 |
| Molecular Weight | 688.7 g/mol |
| Synonyms | N-[2-[2-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]tetrazol-5-yl]-4,5-dimethoxyphenyl]-4-oxochromene-2-carboxamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Encequidar is an inhibitor of the adenosine triphosphate (ATP)-binding cassette (ABC) transporter P-glycoprotein (P-gp), with adjuvant activity.
The listed CAS number is 849675-66-7.
The listed molecular formula is C38H36N6O7.
The listed molecular weight is 688.7 g/mol.
N-[2-[2-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]tetrazol-5-yl]-4,5-dimethoxyphenyl]-4-oxochromene-2-carboxamide.
The source lists Pgp inhibitor hm30181ak and encequidarum.